Journal article
Effectiveness at 1 Year of Monthly versus Variable-Dosing Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Abstract
PURPOSE: To evaluate the visual acuity results of monthly ranibizumab injections compared with a variable-dosing schedule for the treatment of neovascular age-related macular degeneration.
METHODS: A retrospective study that compared two cohorts of consecutive patients. All patients were treatment naive, with baseline visual acuity of 20/400 or better, and completed 12 months of therapy. In the first group all patients received monthly …
Authors
Katz G; Giavedoni L; Muni R; Evans T; Pezda M; Wong D; Moffat A; Altomare F; Boyd S; Berger A
Journal
Retina, Vol. 32, No. 2, pp. 293–298
Publisher
Wolters Kluwer
Publication Date
February 2012
DOI
10.1097/iae.0b013e31821e20b0
ISSN
0275-004X